Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Entasis Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Entasis Therapeutics Raises Additional USD32 Million in Series B-1 Financing 12
Entasis Therapeutics Raises USD50 Million in Series B Financing 14
Entasis Therapeutics Raises USD40 Million in Series A Venture Financing 15
Partnerships 16
Entasis Therapeutics and Global Antibiotic Research & Development Enter into Partnership 16
Licensing Agreements 17
Zai Lab Enters into Licensing Agreement with Entasis Therapeutics 17
Equity Offering 18
Entasis Therapeutics Prices IPO of Shares for USD75 Million 18
Entasis Therapeutics Spin Out from AstraZeneca 20
Entasis Therapeutics Inc – Key Competitors 21
Entasis Therapeutics Inc – Key Employees 22
Entasis Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 14, 2018: Entasis Therapeutics reports third quarter 2018 financial results 24
Corporate Communications 26
May 01, 2018: Entasis Therapeutics Appoints David C. Hastings to Board of Directors 26
Apr 10, 2017: Entasis Appoints Mike Gutch as Chief Financial Officer and Chief Business Officer 27
Product News 28
06/30/2017: Entasis Publishes Data Highlighting the Potent and Differentiated Activity of ETX2514 Combinations against Drug Resistant Gram-negative Bacteria Including Acinetobacter and Pseudomonas 28
06/07/2017: Entasis Therapeutics Presents Data on ETX2514 at ASM Microbe 2017 29
06/06/2018: Entasis Therapeutics to Present Data on ETX0282 at ASM Microbe 2018 30
05/22/2017: Entasis Therapeutics to Present Data on ETX1317 at ASM Microbe 2017 31
05/22/2017: Entasis Therapeutics to Present Data on ETX2514 at ASM Microbe 2017 32
05/22/2017: Entasis Therapeutics to Present Data on ETX0282 at ASM Microbe 2017 33
Clinical Trials 34
Aug 14, 2018: Entasis Therapeutics announces positive topline results from phase 2 trial of ETX2514SUL in patients with complicated urinary tract infections including acute pyelonephritis 34
Jun 06, 2018: Entasis Therapeutics to Present Data on ETX2514 at ASM Microbe 2018 35
May 14, 2018: Entasis Therapeutics Initiates Clinical Studies of the Oral Extended-Spectrum Beta-Lactamase Inhibitor ETX0282 37
Oct 12, 2017: Entasis Therapeutics Receives Second CARB-X Award, Providing up to $10.1 Million for Development of Non-Beta-lactam PBP Inhibitor Program 38
Oct 09, 2017: Entasis Therapeutics Highlights Positive Phase 1 Data for ETX2514 at IDWeek 2017, Announces Plans to Advance Combination with sulbactam (ETX2514SUL) into Phase 2 Trials 39
Sep 28, 2017: Entasis Therapeutics to Present Phase 1 Data on ETX2514 at IDWeek 2017 40
Jun 07, 2017: Entasis Therapeutics Presents Data on Third Drug Candidate, ETX0282, an Orally Available, Extended-Spectrum eta-lactamase Inhibitor, at ASM Microbe 2017 41
Apr 21, 2017: Entasis Therapeutics to Present Data on ETX2514SUL at 27th European Congress of Clinical Microbiology and Infectious Diseases 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Entasis Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Entasis Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Entasis Therapeutics Raises Additional USD32 Million in Series B-1 Financing 12
Entasis Therapeutics Raises USD50 Million in Series B Financing 14
Entasis Therapeutics Raises USD40 Million in Series A Venture Financing 15
Entasis Therapeutics and Global Antibiotic Research & Development Enter into Partnership 16
Zai Lab Enters into Licensing Agreement with Entasis Therapeutics 17
Entasis Therapeutics Prices IPO of Shares for USD75 Million 18
Entasis Therapeutics Spin Out from AstraZeneca 20
Entasis Therapeutics Inc, Key Competitors 21
Entasis Therapeutics Inc, Key Employees 22
List of Figures
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Entasis Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Entasis Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer